PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17128993-8	2006	Both SP-ADEL and SP-AINS mutants as well as wild-type SP-A bound to liposomes containing dipalmitoylphosphatidylcholine and galactosylceramide at equivalent levels, but the abilities of the mutants to induce phospholipid liposome aggregation were significantly less developed than that of the wild type.	Galactosylceramides	124-142	surfactant protein A1	Homo sapiens	5-9	
7525589-9	1994	Antibody 1D6 completely blocked the binding of SP-A to dipalmitoylphosphatidylcholine and galactosylceramide and liposome aggregation.	Galactosylceramides	90-108	surfactant protein A1	Homo sapiens	47-51	
10353843-3	1999	SP-A binds to dipalmitoyl phosphatidylcholine (DPPC) and galactosylceramide (GalCer) and MBP-A binds to phosphatidylinositol (PI).	Galactosylceramides	57-75	surfactant protein A1	Homo sapiens	0-4	
10353843-3	1999	SP-A binds to dipalmitoyl phosphatidylcholine (DPPC) and galactosylceramide (GalCer) and MBP-A binds to phosphatidylinositol (PI).	Galactosylceramides	77-83	surfactant protein A1	Homo sapiens	0-4	
7762796-10	1995	At pH 7.4 and at 5 mM Ca concentration the binding affinity of SP-A followed the order galactosylceramide > lactosylceramide > gangliotetraosylceramide.	Galactosylceramides	87-105	surfactant protein A1	Homo sapiens	63-67	
7762796-12	1995	Binding of SP-A to galactosylceramide was relatively insensitive to pH but increased significantly with increasing Ca concentrations.	Galactosylceramides	19-37	surfactant protein A1	Homo sapiens	11-15	
1577827-10	1992	A recombinant carbohydrate recognition domain (CRD) of human SP-A inhibits the binding of human SP-A to galactosyl ceramide and to galactose- and mannose-bovine serum albumin, indicating that the CRD is directly involved in the binding of SP-A to these ligands.	Galactosylceramides	104-123	surfactant protein A1	Homo sapiens	61-65	
1577827-10	1992	A recombinant carbohydrate recognition domain (CRD) of human SP-A inhibits the binding of human SP-A to galactosyl ceramide and to galactose- and mannose-bovine serum albumin, indicating that the CRD is directly involved in the binding of SP-A to these ligands.	Galactosylceramides	104-123	surfactant protein A1	Homo sapiens	96-100	
1577827-10	1992	A recombinant carbohydrate recognition domain (CRD) of human SP-A inhibits the binding of human SP-A to galactosyl ceramide and to galactose- and mannose-bovine serum albumin, indicating that the CRD is directly involved in the binding of SP-A to these ligands.	Galactosylceramides	104-123	surfactant protein A1	Homo sapiens	96-100